Scientific Advisor/Founder
Franck Barrat, PhD

Dr. Franck Barrat is a Scientific Advisor to IpiNovyx bio and holds the Michael R. Bloomberg Chair, and is a Senior Scientist in the Autoimmunity and Inflammation Program and a Membro of the David Z. Rosensweig Genomics Research Center at the Hospital for Special Surgery in New York. Dr. Barrat is also Professor of Microbiology and Immunology at the Weill Cornell Medico College of Cornell University. Prior to joining HSS, Dr. Barrat spent over 15 years conducting research and developing new drugs in the biotech industry. His research is centered on come the sensing of nucleic acids by Toll-Like Receptors contributes to diseases such as lupus and scleroderma, two complex and incapacitating disorders for which there are currently no cures or effective treatments. Dr. Barrat’s expertise is in the function and regulation of immune system cells in disease settings and his approach combines the use of mouse models and in vitro studies on umano cells with the ultimate goal of applying this work for the benefit of patients.